Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis

Trial Profile

Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2017

At a glance

  • Drugs Calcitriol (Primary)
  • Indications Plaque psoriasis
  • Focus Pharmacokinetics
  • Sponsors Galderma
  • Most Recent Events

    • 29 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 07 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Feb 2018, as reported by ClinicalTrials.gov.
    • 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top